Duodenoscopes Market Information: By Types, (Rigid Duodenoscopes and
Flexible Duodenoscopes), By Application, (Diagnosis and Treatment), By End User
(Gastrologists, General and Pediatric Surgeons, Hospitals, Speciality Clinics,
and Others) - Global Forecast till 2023
Global
Duodenoscopes Market - Overview
Duodenoscope is
flexible, lighted weighted tubes that are released through the mouth, throat,
and stomach into the top of the small intestine. These are specially designed
side viewing endoscope for Endoscopic Retrograde Cholangiopancreatography
(ERCP) procedures, which will help to diagnose diseases associated with
pancreas and bile ducts with the help of fluoroscopic imaging procedure.
Duodenoscopes are being used in more than 650,000 gastrointestinal procedures
in the U.S every year. This is a minimally invasive way to drain out fluids
from biliary and pancreatic ducts which are blocked by cancerous tumors,
gallstones or others. The global Duodenoscopes
Market is expected to grow at a CAGR of 6.83% during the forecast period 2017-2023.
Duodenoscope is a
more complex device with respect to other endoscopes and is tougher to clean
and disinfect. These devices plays an essential role in the treatment of
patients, but there has been some evidences which shows that some patients have
been transmitted with hospital born and other infectious agents, including
antibiotic drug-resistant infections due to these devices. In 2013, the Centers
for Disease Control and Prevention (CDC) alerted the FDA regarding possible
association of multidrug resistant bacterial infections and duodenoscopes. From
January 2013 through December 2014, ERCP was associated with infections in 135
patients.
FUJIFILM Holdings
Corporation, KARL STORZ GmbH & Co. KG, PENTAX Medical, Olympus Corporation,
Custom Ultrasonics, Inc., ENDOMED, and SonoScape and others are some of the
prominent players at the forefront of competition in the global duodenoscopes
market and are profiled in MRFR Analysis.
The market of
duodenoscopes is growing moderately. Increasing prevalence of pancreatic, bile
duct cancer tumors and various gastrointestinal conditions are the major
factors contributing to the growth of the global duodenoscopes market. In
addition, increasing research and development and technological advancements to
identify the causes and risk factors for transmission of infectious agents with
duodenoscopes and developing new solutions to minimize patient exposure is
another major driver, fuelling the global duodenoscopes market growth. However,
increasing FDA recalls for duodenoscopes due to challenging cleaning and
high-level disinfection procedures and rising multidrug-resistant bacterial
infections are major factors which are restraining the growth of global
duodenoscopes market.
According to the
latest WHO report (World Health Organization), in 2015, 8.8 million people died
across the globe from cancer, which is nearly 1 in 6 of all the global deaths.
According to the WHO, approximately 70% of deaths from cancer occur in low- and
middle-income countries. Moreover, according to a report by the World
Gastroenterology Organization, (2014), 35-40% of world’s total population had
acute or chronic GI complication.
Industry Updates
May, 2015
Fujifilm Holdings Corporation has acquired company TeraMedica, Inc., in the
United States
Jan, 2017 PENTAX
Medical had acquired C2 Therapeutics to expand interventional endoscopy
offering
Aug, 2014
Fujifilm, TMDU and Sao Paulo University Hospital signed an agreement for the
promotion of diagnostic system for colorectal cancer in Brazil
Jul, 2017 PENTAX
Medical has announced the collaboration with AOHUA to improve the standard of
patient care and quality of healthcare
Jul, 2016 PENTAX
Medical launched new high-definition pulmonology endoscopy system to deliver
outstanding HD image quality
Browse Full
Report @ https://www.marketresearchfuture.com/reports/duodenoscopes-market-4480
Global
Duodenoscopes Market – Regional:
Geographically,
the regional market is segmented into America, Europe, Asia Pacific, and the
Middle East & Africa.
The Americas
account for the major share of the market owing to the presence of patient
population, well-developed technology, and high healthcare expenditure. To
improve the quality of the diagnosis & treatment, the demand for the
advanced devices have increased. According to the National Institute of
Diabetes and Digestive and Kidney Diseases, approximately 60 to 70 million
people are affected by either major or minor GIT diseases.
Europe holds the
major share of the market, which is majorly contributed by Germany, the U.K.,
and France. The major driving factor of the market are increasing prevalence of
gastrointestinal diseases, increasing government support for development of
healthcare domain, and well developed technology. Moreover, increasing emphasis
on rapid diagnosis and treatment of cancer and infectious diseases, change in
lifestyle, high prevalence of cancer among geriatric population drives this
market in Europe.
Asia Pacific is the
fastest growing duodenoscope market owing to rapidly changing healthcare
sector, and the presence of huge opportunities for the development of this
market. However, the Middle East & Africa has the least share in the market
owing to the presence of poor and slow developing countries, especially, in
African region. The Middle East holds the major share of the regional market due
to well-developed technology and high spending.
No comments:
Post a Comment